Molecular radiobiology meets clinical radiation oncology

References

• Abdollahi A, Griggs DW, Zieher H, Roth A, Lipson KE, Saffrich R, Grone HJ, Hallahan DE, Reisfeld RA, Debus J, Niethammer AG, Huber PE. 2005. Inhibition of alpha(v)beta3 integrin survival signaling enhances antiangiogenic and antitumor effects of radiotherapy. Clinical Cancer Research. 11:6270–6279.
   PubMed Web of Science ®Google Scholar
• Ashkenazi A. 2008. Directing cancer cells to self-destruct with pro-apoptotic receptor agonists. Nature Reviews Drug Discovery. 7:1001–1012.
   PubMed Web of Science ®Google Scholar
• Baumann M, Krause M, Hill R. 2008. Clonogens and cancer stem cells. Nature Reviews Cancer. 8:545–554.
   PubMed Web of Science ®Google Scholar
• Beck R, Roper B, Carlsen JM, Huisman MC, Lebschi JA, Andratschke N, Picchio M, Souvatzoglou M, Machulla HJ, Piert M. 2007. Pretreatment 18F-FAZA PET predicts success of hypoxia-directed radiochemotherapy using tirapazamine. Journal of Nuclear Medicine. 48:973–980.
   PubMed Web of Science ®Google Scholar
• Beer AJ, Grosu AL, Carlsen J, Kolk A, Sarbia M, Stangier I, Watzlowik P, Wester HJ, Haubner R, Schwaiger M. 2007. [18F]galacto-RGD positron emission tomography for imaging of alphavbeta3 expression on the neovasculature in patients with squamous cell carcinoma of the head and neck. Clinical Cancer Research. 13:6610–6616.
   PubMed Web of Science ®Google Scholar
• Bentzen SM. 2006. Preventing or reducing late side effects of radiation therapy: Radiobiology meets molecular pathology. Nature Reviews Cancer. 6:702–713.
   PubMed Web of Science ®Google Scholar
• Bernier J, Bentzen SM, Vermorken JB. 2009. Molecular therapy in head and neck oncology. Nature Reviews Clinical Oncology. 6:266–277.
   PubMed Web of Science ®Google Scholar
• Bieler A, Mantwill K, Holzmuller R, Jurchott K, Kaszubiak A, Stark S, Glockzin G, Lage H, Grosu AL, Gansbacher B, Holm PS. 2008. Impact of radiation therapy on the oncolytic adenovirus dl520: Implications on the treatment of glioblastoma. Radiotherapy Oncology. 86:419–427.
   PubMed Web of Science ®Google Scholar
• Brabletz T, Jung A, Spaderna S, Hlubek F, Kirchner T. 2005. Opinion: Migrating cancer stem cells – an integrated concept of malignant tumour progression. Nature Reviews Cancer. 5:744–749.
   PubMed Web of Science ®Google Scholar
• Capalbo G, Rodel C, Stauber RH, Knauer SK, Bache M, Kappler M, Rodel F. 2007. The role of survivin for radiation therapy. Prognostic and predictive factor and therapeutic target. Strahlentherapie und Onkologie. 183:593–599.
   PubMed Web of Science ®Google Scholar
• Coppes RP, van der Goot A, Lombaert IM. 2009. Stem cell therapy to reduce radiation-induced normal tissue damage. Seminars in Radiation Oncology. 19:112–121.
   PubMed Web of Science ®Google Scholar
• Cowen RL, Garside EJ, Fitzpatrick B, Papadopoulou MV, Williams KJ. 2008. Gene therapy approaches to enhance bioreductive drug treatment. The British Journal of Radiology. 81(Spec. No. 1): S45–56.
   Google Scholar
• Doil C, Mailand N, Bekker-Jensen S, Menard P, Larsen DH, Pepperkok R, Ellenberg J, Panier S, Durocher D, Bartek J, Lukas J, Lukas C. 2009. RNF168 binds and amplifies ubiquitin conjugates on damaged chromosomes to allow accumulation of repair proteins. Cell. 136:435–446.
   PubMed Web of Science ®Google Scholar
• Downs JA, Nussenzweig MC, Nussenzweig A. 2007. Chromatin dynamics and the preservation of genetic information. Nature. 447:951–958.
   PubMed Web of Science ®Google Scholar
• Duda DG, Jain RK, Willett CG. 2007. Antiangiogenics: The potential role of integrating this novel treatment modality with chemoradiation for solid cancers. Journal of Clinical Oncology. 25:4033–4042.
   PubMed Web of Science ®Google Scholar
• Firat E, Tsurumi C, Gaedicke S, Huai J, Niedermann G. 2009. Tripeptidyl peptidase II plays a role in the radiation response of selected primary cell types but not based on nuclear translocation and p53 stabilization. Cancer Research. 69:3325–3331.
   PubMed Web of Science ®Google Scholar
• Fodde R, Brabletz T. 2007. Wnt/beta-catenin signaling in cancer stemness and malignant behavior. Current Opinion in Cell Biology. 19:150–158.
   PubMed Web of Science ®Google Scholar
• Formenti SC, Demaria S. 2008. Local control by radiotherapy: Is that all there is? Breast Cancer Research. 10:215.
   PubMed Web of Science ®Google Scholar
• Frey B, Munoz LE, Pausch F, Sieber R, Franz S, Brachvogel B, Poschl E, Schneider H, Rodel F, Sauer R, Fietkau R, Herrmann M, Gaipl US. 2008. The immune reaction against allogeneic necrotic cells is reduced in AnnexinA5 knock out mice whose macrophages display an anti-inflammatory phenotype. Journal of Cellular and Molecular Medicine. 13:1391–1399.
   PubMed Web of Science ®Google Scholar
• Gasser S, Raulet DH. 2006. The DNA damage response arouses the immune system. Cancer Research. 66:3959–3962.
   PubMed Web of Science ®Google Scholar
• Gehrmann M, Radons J, Molls M, Multhoff G. 2008. The therapeutic implications of clinically applied modifiers of heat shock protein 70 (Hsp70) expression by tumor cells. Cell Stress Chaperones. 13:1–10.
   PubMed Web of Science ®Google Scholar
• Greubel C, Hable V, Drexler GA, Hauptner A, Dietzel S, Strickfaden H, Baur I, Krucken R, Cremer T, Dollinger G, Friedl AA. 2008. Competition effect in DNA damage response. Radiation and Environmental Biophysics. 47:423–429.
   PubMed Web of Science ®Google Scholar
• Grosu AL, Souvatzoglou M, Roper B, Dobritz M, Wiedenmann N, Jacob V, Wester HJ, Reischl G, Machulla HJ, Schwaiger M, Molls M, Piert M. 2007. Hypoxia imaging with FAZA-PET and theoretical considerations with regard to dose painting for individualization of radiotherapy in patients with head and neck cancer. International Journal Radiation Oncology Biology Physics. 69:541–551.
   PubMed Web of Science ®Google Scholar
• Harper JW, Elledge SJ. 2007. The DNA damage response: Ten years after. Molecular Cell. 28:739–745.
   PubMed Web of Science ®Google Scholar
• Hensley ML, Hagerty KL, Kewalramani T, Green DM, Meropol NJ, Wasserman TH, Cohen GI, Emami B, Gradishar WJ, Mitchell RB, Thigpen JT, Trotti A 3rd, von Hoff D, Schuchter LM. 2008. American Society of Clinical Oncology 2008 Clinical Practice Guideline Update: Use of chemotherapy and radiation therapy protectants. Journal of Clinical Oncology. 27:127–145.
   PubMed Web of Science ®Google Scholar
• Hill RP, Marie-Egyptienne DT, Hedley DW. 2009. Cancer stem cells, hypoxia and metastasis. Seminars in Radiation Oncology. 19:106–111.
   PubMed Web of Science ®Google Scholar
• Hsu PP, Sabatini DM. 2008. Cancer cell metabolism: Warburg and beyond. Cell. 134:703–707.
   PubMed Web of Science ®Google Scholar
• Huai J, Firat E, Nil A, Million D, Gaedicke S, Kanzler B, Freudenberg M, van Endert P, Kohler G, Pahl HL, Aichele P, Eichmann K, Niedermann G. 2008. Activation of cellular death programs associated with immunosenescence-like phenotype in TPPII knockout mice. Proceedings of the National Academy of Sciences of the USA. 105:5177–5182.
   PubMed Web of Science ®Google Scholar
• Huber PE, Bischof M, Jenne J, Heiland S, Peschke P, Saffrich R, Grone HJ, Debus J, Lipson KE, Abdollahi A. 2005. Trimodal cancer treatment: Beneficial effects of combined antiangiogenesis, radiation, and chemotherapy. Cancer Research. 65:3643–3655.
   PubMed Web of Science ®Google Scholar
• Jain RK, di Tomaso E, Duda DG, Loeffler JS, Sorensen AG, Batchelor TT. 2007. Angiogenesis in brain tumours. Nature Reviews Neuroscience. 8:610–622.
   PubMed Web of Science ®Google Scholar
• Jung JW, Hwang SY, Hwang JS, Oh ES, Park S, Han IO. 2007. Ionising radiation induces changes associated with epithelial-mesenchymal transdifferentiation and increased cell motility of A549 lung epithelial cells. European Journal of Cancer. 43:1214–1224.
   PubMed Web of Science ®Google Scholar
• Kepp O, Tesniere A, Zitvogel L, Kroemer G. 2009. The immunogenicity of tumor cell death. Current Opinion in Oncology. 21:71–76.
   PubMed Web of Science ®Google Scholar
• Knopf A, Parodi K, Paganetti H, Cascio E, Bonab A, Bortfeld T. 2008. Quantitative assessment of the physical potential of proton beam range verification with PET/CT. Physics in Medicine and Biology. 53:4137–4151.
   PubMed Web of Science ®Google Scholar
• Lobrich M, Jeggo PA. 2007. The impact of a negligent G2/M checkpoint on genomic instability and cancer induction. Nature Reviews Cancer. 7:861–869.
   PubMed Web of Science ®Google Scholar
• Lombaert IM, Brunsting JF, Wierenga PK, Faber H, Stokman MA, Kok T, Visser WH, Kampinga HH, de Haan G, Coppes RP. 2008. Rescue of salivary gland function after stem cell transplantation in irradiated glands. PLoS ONE. 3:e2063.
   PubMed Web of Science ®Google Scholar
• Mailand N, Bekker-Jensen S, Faustrup H, Melander F, Bartek J, Lukas C, Lukas J. 2007. RNF8 ubiquitylates histones at DNA double-strand breaks and promotes assembly of repair proteins. Cell. 131:887–900.
   PubMed Web of Science ®Google Scholar
• Mansour WY, Schumacher S, Rosskopf R, Rhein T, Schmidt-Petersen F, Gatzemeier F, Haag F, Borgmann K, Willers H, Dahm-Daphi J. 2008. Hierarchy of nonhomologous end-joining, single-strand annealing and gene conversion at site-directed DNA double-strand breaks. Nucleic Acids Research. 36:4088–4098.
   PubMed Web of Science ®Google Scholar
• Marini P, Budach V, Niyazi M, Junginger D, Stickl S, Jendrossek V, Belka C. 2009. Combination of pro-apoptotic TRAIL-receptor antibodies with ionizing radiation strongly increases long term tumor control under ambient and hypoxic conditions. International Journal Radiation Oncology Biology Physics. 75:198–202.
   PubMed Web of Science ®Google Scholar
• McKeown SR, Cowen RL, Williams KJ. 2007. Bioreductive drugs: From concept to clinic. Clinical Oncology. 19:427–442.
   PubMed Web of Science ®Google Scholar
• Meyn RE, Milas L, Ang KK. 2009. The role of apoptosis in radiation oncology. International Journal of Radiation Biology. 85:107–115.
   PubMed Web of Science ®Google Scholar
• Nieder C, Wiedenmann N, Andratschke N, Molls M. 2006. Current status of angiogenesis inhibitors combined with radiation therapy. Cancer Treatment Reviews. 32:348–364.
   PubMed Web of Science ®Google Scholar
• Niyazi M, Marini P, Daniel PT, Humphreys RH, Jendrossek V, Belka C. 2009. Efficacy of a triple treatment with irradiation, agonistic TRAIL receptor antibodies and EGFR blockade. Strahlentherapie und Onkologie. 185:8–18.
   PubMed Web of Science ®Google Scholar
• Oehler-Janne C, Jochum W, Riesterer O, Broggini-Tenzer A, Caravatti G, Vuong V, Pruschy M. 2007. Hypoxia modulation and radiosensitization by the novel dual EGFR and VEGFR inhibitor AEE788 in spontaneous and related allograft tumor models. Molecular Cancer Therapeutics. 6:2496–2504.
   PubMed Web of Science ®Google Scholar
• Orlowski RZ, Kuhn DJ. 2008. Proteasome inhibitors in cancer therapy: Lessons from the first decade. Clinical Cancer Research. 14:1649–1657.
   PubMed Web of Science ®Google Scholar
• Pan JG, Mak TW. 2007. Metabolic targeting as an anticancer strategy: Dawn of a new era? Science's Signal Transduction Knowledge Environment. 2007: pe14.
   PubMedGoogle Scholar
• Quennet V, Yaromina A, Zips D, Rosner A, Walenta S, Baumann M, Mueller-Klieser W. 2006. Tumor lactate content predicts for response to fractionated irradiation of human squamous cell carcinomas in nude mice. Radiotherapy Oncology. 81:130–135.
   PubMed Web of Science ®Google Scholar
• Rich JN. 2007. Cancer stem cells in radiation resistance. Cancer Research. 67:8980–8984.
   PubMed Web of Science ®Google Scholar
• Riesterer O, Honer M, Jochum W, Oehler C, Ametamey S, Pruschy M. 2006. Ionizing radiation antagonizes tumor hypoxia induced by antiangiogenic treatment. Clinical Cancer Research. 12:3518–3524.
   PubMed Web of Science ®Google Scholar
• Rischin D, Hicks RJ, Fisher R, Binns D, Corry J, Porceddu S, Peters LJ. 2006. Prognostic significance of [18F]-misonidazole positron emission tomographydetected tumor hypoxia in patients with advanced head and neck cancer randomly assigned to chemoradiation with or without tirapazamine: A substudy of Trans-Tasman Radiation Oncology Group Study 98.02. Journal of Clinical Oncology. 24:2098–2104.
   PubMed Web of Science ®Google Scholar
• Rodemann HP, Dittmann K, Toulany M. 2007. Radiation-induced EGFR-signaling and control of DNA-damage repair. International Journal Radiation Biology. 83:781–791.
   PubMed Web of Science ®Google Scholar
• Rosenthal DI, Trotti A. 2009. Strategies for managing radiation-induced mucositis in head and neck cancer. Seminars in Radiation Oncology. 19:29–34.
   PubMed Web of Science ®Google Scholar
• Schutze C, Bergmann R, Yaromina A, Hessel F, Kotzerke J, Steinbach J, Baumann M, Beuthien-Baumann B. 2007. Effect of increase of radiation dose on local control relates to pre-treatment FDG uptake in FaDu tumours in nude mice. Radiotherapy Oncology. 83:311–315.
   PubMed Web of Science ®Google Scholar
• Unkelbach J, Chan TC, Bortfeld T. 2007. Accounting for range uncertainties in the optimization of intensity modulated proton therapy. Physics in Medicine and Biology. 52:2755–2773.
   PubMed Web of Science ®Google Scholar
• Wiegman EM, Blaese MA, Loeffler H, Coppes RP, Rodemann HP. 2007. TGFbeta-1 dependent fast stimulation of ATM and p53 phosphorylation following exposure to ionizing radiation does not involve TGFbeta-receptor I signalling. Radiotherapy Oncology. 83:289–295.
   PubMed Web of Science ®Google Scholar
• Willers H, Dahm-Daphi J, Powell SN. 2004. Repair of radiation damage to DNA. British Journal of Cancer. 90:1297–1301.
   PubMed Web of Science ®Google Scholar
• Willett CG, Duda DG, di Tomaso E, Boucher Y, Czito BG, Vujaskovic Z, Vlahovic G, Bendell J, Cohen KS, Hurwitz HI, Bentley R, Lauwers GY, Poleski M, Wong TZ, Paulson E, Ludwig KA, Jain RK. 2007. Complete pathological response to bevacizumab and chemoradiation in advanced rectal cancer. Nature Clinical Practice Oncology. 4:316–321.
   PubMedGoogle Scholar
• Winkler F, Kozin SV, Tong RT, Chae SS, Booth MF, Garkavtsev I, Xu L, Hicklin DJ, Fukumura D, di Tomaso E, Munn LL, Jain RK. 2004. Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: Role of oxygenation, angiopoietin-1, and matrix metalloproteinases. Cancer Cell. 6:553–563.
   PubMed Web of Science ®Google Scholar
• Woodward WA, Bristow RG. 2009. Radiosensitivity of cancer-initiating cells and normal stem cells (or what the Heisenberg uncertainly principle has to do with biology). Seminars in Radiation Oncology. 19:87–95.
   PubMed Web of Science ®Google Scholar
• Woodward WA, Bristow RG, Clarke MF, Coppes RP, Cristofanilli M, Duda DG, Fike JR, Hambardzumyan D, Hill RP, Jordan CT, Milas L, Pajonk F, Curran WJ, Dicker AP, Chen Y. 2009. Radiation Therapy Oncology Group Translational Research Program Stem Cell Symposium: Incorporating stem cell hypotheses into clinical trials. International Journal Radiation Oncology Biology Physics. 74:1580–1591.
   PubMed Web of Science ®Google Scholar
• Woodward WA, Chen MS, Behbod F, Alfaro MP, Buchholz TA, Rosen JM. 2007. WNT/beta-catenin mediates radiation resistance of mouse mammary progenitor cells. Proceedings of the National Academy of Sciences of the USA. 104:618–623.
   PubMed Web of Science ®Google Scholar
• Yaromina A, Krause M, Thames H, Rosner A, Krause M, Hessel F, Grenman R, Zips D, Baumann M. 2007. Pre-treatment number of clonogenic cells and their radiosensitivity are major determinants of local tumour control after fractionated irradiation. Radiotherapy Oncology. 83:304–310.
   PubMed Web of Science ®Google Scholar
• Yaromina A, Zips D, Thames HD, Eicheler W, Krause M, Rosner A, Haase M, Petersen C, Raleigh JA, Quennet V, Walenta S, Mueller-Klieser W, Baumann M. 2006. Pimonidazole labelling and response to fractionated irradiation of five human squamous cell carcinoma (hSCC) lines in nude mice: The need for a multivariate approach in biomarker studies. Radiotherapy Oncology. 81:122–129.
   PubMed Web of Science ®Google Scholar
• Zhang P, Castedo M, Tao Y, Violot D, Metivier D, Deutsch E, Kroemer G, Bourhis J. 2006. Caspase independence of radio-induced cell death. Oncogene. 25:7758–7770.
   PubMed Web of Science ®Google Scholar
• Zips D, Krause M, Yaromina A, Dorfler A, Eicheler W, Schutze C, Gurtner K, Baumann M. 2008. Epidermal growth factor receptor inhibitors for radiotherapy: Biological rationale and preclinical results. Journal of Pharmacy and Pharmacology. 60:1019–1028.
   PubMed Web of Science ®Google Scholar